Appili Therapeutics Receives FDA and Health Canada Clearance to Begin Clinical Trials on ATI-1501
Appili Therapeutics Receives FDA and Health Canada Clearance to Begin [...]
Newsletter Sign Up
Recent Posts
- Canada in Science – June 10, 2019
- Resverlogix Announces Closing of $15 Million Offering
- HLS Therapeutics Announces Closing of $50 Million Bought Deal Offering
- Greenbrook TMS Completes CAD $30 Million Bought Deal Public Offering and Concurrent Private Placement
- Three Finalists Announced for the 2019 Bloom Burton Award